申请人:Page Patrick
公开号:US08796280B2
公开(公告)日:2014-08-05
The present invention is related to the use of 2,3 substituted pyrazine sulfonamides of formula (I)
for the treatment and/or prevention of allergic diseases, inflammatory dermatoses and other diseases with an inflammatory component. Specifically, the present invention is related to the use of 2,3 substituted pyrazine sulfonamides for the modulation, notably the inhibition, of CRTH2 activity.
本发明涉及使用2,3取代的吡嗪磺酰胺(式(I))治疗和/或预防过敏性疾病、炎症性皮肤病和其他具有炎症成分的疾病。具体而言,本发明涉及使用2,3取代的吡嗪磺酰胺来调节,特别是抑制CRTH2活性。